Tag: Priority review

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Priority review

FDA Action Alert: Merck, BMS, Sarepta and More | BioSpace

Added to Collection on: 2024-06-17 04:10:08

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Merck & Co.
Sarepta Therapeutics
KRAS
Gene therapy
Narcolepsy
Priority review
Food and Drug Administration
Cetuximab

Click the tags to see associated articles and topics

View Article Details
Applied Therapeutics' SWOT analysis: rare disease biopharma stock faces regulatory hurdles

Added to Collection on: 2024-12-16 19:15:45

Tags for this article:

Pharmacy
Pharmaceutical industry
Pharmacology
Food and Drug Administration
Biopharmaceutical
Priority review

Click the tags to see associated articles and topics

View Article Details
INmune Bio Announces Plan to Submit FDA Biologics License Applic - GuruFocus

Added to Collection on: 2025-02-11 11:43:40

Tags for this article:

Drug discovery
Genodermatoses
Rare diseases
Clinical research
Food and Drug Administration
Epidermolysis bullosa dystrophica
Epidermolysis bullosa
Clinical trial
Priority review
Drug development
Collagen, type VII, alpha 1
Orphan drug
INmune Bio Inc.
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Iopofosine-131 Earns FDA Breakthrough for Waldenstrom Macroglobulinemia - Cure Today

Added to Collection on: 2025-06-05 15:20:30

Tags for this article:

Orphan drugs
Food and Drug Administration
Pharmaceuticals policy
Pharmacy
Biotechnology law
Breakthrough therapy
Fast track
Priority review
Umbralisib

Click the tags to see associated articles and topics

View Article Details
China's NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor

Added to Collection on: 2025-06-10 20:55:01

Tags for this article:

Anilides
Pimicotinib
Pyrazoles
Pyridines
Ureas
Food and Drug Administration
Tenosynovial giant cell tumor
Priority review
Merck KGaA

Click the tags to see associated articles and topics

View Article Details
Armistice Capital, Vanguard, and Wellington Take Positions - FintechZoom

Added to Collection on: 2025-07-01 08:29:16

Tags for this article:

Biotechnology
PTC Therapeutics
South Plainfield, New Jersey
Institutional investor
Hedge fund
Novartis
Short
BlackRock
Priority review
PTC Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI ...

Added to Collection on: 2025-07-08 15:10:43

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Applied genetics
Muscular dystrophy
Delandistrogene moxeparvovec
Gene therapy
Palantir Technologies
Duchenne muscular dystrophy
Priority review
United States

Click the tags to see associated articles and topics

View Article Details
Why an FDA decision on Stealth's Barth drug could ripple through the rare disease field

Added to Collection on: 2025-08-26 17:41:31

Tags for this article:

Food and Drug Administration
Priority review
Stealth
Lindsay Marjoram
STEALTH BIOTHERAPEUTICS
Reenie McCarthy

Click the tags to see associated articles and topics

View Article Details
REGN Loses 21.1% Year to Date: Buy, Sell or Hold the Sock? - TradingView

Added to Collection on: 2025-09-15 15:32:00

Tags for this article:

Sanofi
Regeneron Pharmaceuticals
Aflibercept
Macular edema
Bayer
Dupilumab
Cemiplimab
Central retinal vein occlusion
Priority review
Eylea
S&P 500 INDEX - CBOE

Click the tags to see associated articles and topics

View Article Details
Health Canada approves Santhera's Agamree for DMD treatment

Added to Collection on: 2025-10-06 07:39:34

Tags for this article:

Muscular dystrophy
Rare diseases
Duchenne muscular dystrophy
Vamorolone
Catalyst Pharmaceuticals
DMD
Priority review
Dystrophin
Prosensa

Click the tags to see associated articles and topics

View Article Details
Book a Demo